These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 448286)

  • 1. H-2 I-region encoded targets in allograft rejection.
    Gose JE; Bach FH
    J Exp Med; 1979 May; 149(5):1254-9. PubMed ID: 448286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex antigen expression of parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection.
    La Rosa FG; Talmage DW
    Transplantation; 1990 Mar; 49(3):605-9. PubMed ID: 1690472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts.
    La Rosa FG; Talmage DW
    Transplantation; 1985 May; 39(5):480-5. PubMed ID: 3992648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of organ culture on the survival of thyroid allografts in mice.
    Lafferty KJ; Bootes A; Dart G; Talmage DW
    Transplantation; 1976 Aug; 22(2):138-49. PubMed ID: 61634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.
    Hullett DA; Landry AS; Leonard DK; Sollinger HW
    Transplantation; 1989 Jan; 47(1):24-7. PubMed ID: 2911873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid allograft immunogenicity is reduced after a period in organ culture.
    Lafferty KJ; Cooley MA; Woolnough J; Walker KZ
    Science; 1975 Apr; 188(4185):259-61. PubMed ID: 1118726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of thyroid allograft rejection.
    Lafferty KJ; Bootes A; Killby VA; Burch W
    Aust J Exp Biol Med Sci; 1976 Dec; 54(6):573-86. PubMed ID: 1027412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice.
    Donohoe JA; Andrus L; Bowen KM; Simeonovic C; Prowse SJ; Lafferty KJ
    Transplantation; 1983 Jan; 35(1):62-7. PubMed ID: 6823693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of variability in responses to class-I-antigen-disparate thyroid grafts.
    Isakov N; Bach FH
    Transplantation; 1985 Mar; 39(3):303-9. PubMed ID: 3919481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The origin and mechanism of the allograft reaction.
    Lafferty KJ; Woolnough J
    Immunol Rev; 1977; 35():231-62. PubMed ID: 330389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to cultured allografts protects third-party grafts containing new MHC and common minor antigens.
    La Rosa FG; Talmage DW
    Transplantation; 1987 Feb; 43(2):314-6. PubMed ID: 3580040
    [No Abstract]   [Full Text] [Related]  

  • 14. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitized Lyt-2+ T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens.
    Warren HS; Simeonovic CJ; Dixon JE; Pembrey RG; Lafferty KJ
    Transplant Proc; 1986 Apr; 18(2):310-2. PubMed ID: 3083544
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection.
    Talmage DW; Dart G; Radovich J; Lafferty KJ
    Science; 1976 Jan; 191(4225):385-8. PubMed ID: 1082167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of histocompatibility and transplant site on survival.
    Perloff LJ; Utiger RD; Alavi A; Barker CF
    Ann Surg; 1978 Aug; 188(2):186-96. PubMed ID: 686886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-2K region-controlled products of the murine major histocompatibility complex differ in their immunogenic capacity when expressed on different tissues.
    Isakov N; Feldman M; Segal S
    Transplantation; 1981 Oct; 32(4):291-5. PubMed ID: 6173938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
    Klein J; Geib R; Chiang C; Hauptfeld V
    J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.